Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 8th – 14th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
10. Red White & Bloom Updates Investors on High Times Deal, U.S. Operations and Share Lockup Following Successful IPO
Over 70% of RWB’s Shares, Including Shares Held By Management and Founders, Are Under Lockup, Escrow or Some Form of Trading Restriction
Red White & Bloom Brands (OTC:TDRYD) provided an investor update following the competition of its reverse takeover of Tidal Royalty, which saw RWB shares commence trading on the CSE. RWB also announced a blockbuster deal with High Times to acquire the licensing and branding rights for High Times dispensaries and cannabis products in Michigan, Illinois and Florida.
READ FULL RED WHITE & BLOOM ARTICLE
9. Champignon Brands Closes $15 Million Bought Deal Private Placement + SHRM Chart Analysis
The Champignon Brands Offering Included the Full Exercise of Options Granted to the Deal’s Underwriters
Proceeds of the financing will allow Champignon Brands (OTCQB:SHRMF) to accelerate its North American Psychedelics clinic expansion program.
READ FULL CHAMPIGNON BRANDS ARTICLE
8. Forget Xanax. This Company Wants You to Take a Large Dose of LSD
MindMed is Asking the FDA for Permission to Begin a Human Trial in the U.S., Where Therapists Would Give “Experiential” Soses of LSD to Patients
If you want to get a feel for the level of anxiety in America right now, look no further than Xanax prescriptions. But what if there were a non-addictive alternative to treating anxiety? Psychedelic pharmaceutical company MindMed (OTCQB:MMEDF) says there is. It’s called LSD, and they’re going to the FDA to prove it.
READ FULL MINDMED ARTICLE
7. TraderTV Live Interviews Brad Rogers, CEO of Super State Operator Red White & Bloom
RWB CEO Brad Rogers Provides Investors With a Preview of RWB’s Plans For 2020 and Beyond
Rogers also discusses Red White & Bloom’s (OTC:TDRYD) successful IPO, landmark High Times deal, the meaning of Super State Operator and much more.
WATCH FULL RWB VIDEO
6. Should I Sell My Aurora Cannabis Stock?
Here’s Your Definitive Answer
One such stock that I suspect many investors are evaluating right now is Aurora Cannabis (NYSE:ACB). Some who bought Aurora are no doubt wishing they had bailed out sooner.
READ FULL AURORA CANNABIS ARTICLE
5. Here’s When Canopy Growth’s CEO Thinks the U.S. Pot Market Will Be Open for Business
David Klein Says That Federal Legalization is on its Way No Matter Who Wins in November
The one thing that could send Pot Stocks soaring in a hurry is the federal legalization of marijuana in the U.S. If and when that happens, it’ll not only be possible for cannabis companies to move their products legally across state lines but it could also result in a flurry of mergers and acquisitions. Canadian companies like Canopy Growth (NYSE:CGC) are especially eager to tap into the lucrative U.S. pot market.
READ FULL CANOPY GROWTH ARTICLE
4. Champignon Brands Investor Update: Name Change, Corporate Rebranding and Planned CPG Spin Out
Champignon Also Announced it is Considering Spinning Out its CPG Business and if it Happens, Current SHRM Shareholders Would Get a Piece of the New Company
It’s been an incredible year to date for the Psychedelics leader Champignon Brands (OTCQB:SHRMF), here’s a list of the company’s top accomplishments and milestones over the last quarter.
READ FULL CHAMPIGNON ARTICLE
3. 2 Cannabis Stocks That Should Survive the COVID-19 Crisis
These Pot Companies Are Prioritizing What’s Essential to Stay Afloat During a Pandemic
In most places, the marijuana industry was deemed essential amid widespread lockdowns — which is why revenue is pouring in for the sector. While some Cannabis Stocks are shining — namely the U.S. cannabis companies — others are still recovering from their losses from 2019. Then, there are Cronos Group (NASDAQ:CRON) and Aphria (NYSE:APHA), which are focused on staying afloat with their strong balance sheets.
READ FULL CANNABIS STOCKS ARTICLE
2. Investing in Psychedelics Stocks
I’ve Been Telling You About This Burgeoning Market for the Past Few Months, and it Reminds Me a Lot of the Cannabis Market
Because once again, in defiance of federal prohibition, I’m enjoying both the medicinal benefits of psychedelics and the financial benefits, too.
READ FULL PSYCHEDELIC STOCKS ARTICLE
1. Red White & Bloom Closes Landmark High Times Deal
RWB Also Locked Down the U.S. Nationwide Rights to the High Times Hemp-Derived CBD Brand Culture
Red White & Bloom Brands (OTC:TDRYD) announced the closing of its previously announced deal to acquire the licensing rights for the branding of High Times dispensaries and High Times cannabis-based CBD and THC products in the States of Michigan, Illinois and Florida. The deal combines the largest midwest cannabis operation boasting 350,000 transactions per year with the world’s most Iconic marijuana brand for over 46 years.
READ FULL RWB HIGH TIMES ARTICLE
Photo by Rick Proctor on Unsplash
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.